<DOC>
	<DOCNO>NCT01373749</DOCNO>
	<brief_summary>Nitro Oxide ( NO ) inhalation recognize effect treatment Neonatal Persistent Pulmonary Hypertension ( PPHN ) , safety NO long term application investigation . Several research suggest much NO2 generate lung long term ( &gt; 72h ) use NO inhalation , cause bad effect PS production . Sildenafil prove effective PPHN NO . This medication similar clinical effect need monitor blood pressure . The possible hypotension effect restrict dosage sildenafil , limit usage sildenafil severe PPHN . But recommend sildenafil The purpose study establish NO continued sildenafil effect single NO inhalation .</brief_summary>
	<brief_title>Nitro Oxide Inhalation Continued With Sildenafil Neonatal Persistent Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Persistent Fetal Circulation Syndrome</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Diagnosed PPHN NICU , primary disease : neonate respiratory distress syndrome , meconium aspiration syndrome newborn , severe neonatal infectious pneumonia . Pulmonary artery pressure &gt; 50mmHg mechanical ventilation 48h primary OI ( PO2/FiO2 ) &lt; 300 difference SpO2 low limb &gt; 10 % high FiO2 oxygen inhalation test : positive congenital heart disease diaphragmatic hernia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>PPHN</keyword>
	<keyword>NO inhalation</keyword>
	<keyword>Sildenafil</keyword>
	<keyword>Treatment</keyword>
	<keyword>Safety</keyword>
</DOC>